|
|
| Titles |
1993 Canadian Journal of Psychiatry Modecate |
| Related Item |
|
| Genre |
medicine |
| Genre |
medicines (psychiatric) |
| Identifier |
cjp1993aug_sep_oct_nov_dec16 |
| Note |
Fewer schizophrenic relapses, more comfortable injections, lower cost. No you're not hallucinating. Fewer schizophrenic relapses. On average, depot neuroleptics have relapse rates significantly lower than oral therapies because patients are often non-compliant with oral treatments. Most comfortable injections. Lower injection volumes means less painful injections and modecate concentrate is the lowest volume neuroleptic. Lower cost. Modecate's price is concentrated, too. It costs less than other leading depot neuroleptics and up to thousands of dollars less annually than some oral therapies, based on comparable dosing regimens. Reality. More physicians have good reason to feel comfortable prescribing Modecate concentrate. Modecate concentrate a comfortable reality. |
| Abstract |
Fluphenazine Decanoate, Bristol-Myers Squibb, A syringe and medicine bottle is pictured. Also part of the text is coloured in black and yellow and written in a spiral pattern. |
